Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @TBattelino
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TBattelino
-
Tadej Battelino proslijedio/la je Tweet
Great workshop today from my colleague Dr Dominic Bray. Great to hear all of the amazing work happening in paediatric diabetes.
#ACDCAston Here are a few of the good things we heard in response to “so... what’s going well already?” :pic.twitter.com/9xHa92QcvC
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je Tweet
Secure your spot for ATTD 2020 in time! Join us at the ultimate meeting place for diabetes technology! Savings are available until 5 February 2020.
-
Tadej Battelino proslijedio/la je Tweet
#BrexitDay won’t stop academic collaborations with colleagues in Europe and around the world...pic.twitter.com/wIxz5spF3I
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je Tweet
Access the updated 2020 Standards of Medical Care in Diabetes app now! https://bit.ly/2NE5T5D pic.twitter.com/L4BXE5QQH6
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je Tweet
In India,
#Crohns disease incidence is rising. A new Helmsley grant will screen patients in need, help raise awareness, and prevent misdiagnosis of the disease: https://helmsleytrust.org/news/helmsley-charitable-trust-funds-asian-healthcare-foundation-southern-india-improve-care-crohns … Pictured, Dr. Rupa Banerjee, lead PI on the grant project.pic.twitter.com/UPFu3w0rcF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je Tweet
Another day filming modules for the
@DTN_UK education modules for CGM and closed loop with@DigiBeteUK. Thanks@MEvansCambridge@geraldinegallen@kt_davenport@Sarahartnell1 for your expert presentations: look out for news on launch@parthaskar@ABCDiab@DSNforumUKpic.twitter.com/pnb7m3PTkQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Prof Biffi: gene therapies work in clinical routine and have potential also in
#diabetes@UniPadovapic.twitter.com/kaqU6LE2O2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Piemonti: “the individual who’s
#diabetes will be cured by cell therapies is alredy born”


Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je Tweet
https://adc.bmj.com/content/early/2019/09/15/archdischild-2019-317800 …
@ACDC_UK published the variations in care to access in technology for children with#diabetes and it has to stop...Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je Tweet
Better glycaemic variability and time in range with dapagliflozin vs gliclazide MR in T2 diabetes- is it of clinical significance? https://onlinelibrary.wiley.com/doi/full/10.1111/dom.13913?campaign=wolearlyview …
@DSNforumUK@youngdiab@ABCDiab@AmarPut@AbdTahrani@drpatrickholmes@redGDPS@parthaskar@drpratikc@WilmotEmmaHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Prof Lorenzo Piemonti on cell therapies for type 1
#diabetes “we are closer to success”

@UniPadova@sanrafaelepic.twitter.com/4AI2frjVd7
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Prof Daniela Bruttomesso on the future
#diabetes technologies@UniPadovapic.twitter.com/kfkrZxmkWi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je Tweet
“Control-IQ clearance isn’t a step for automated insulin delivery, it’s a leap,” said
@TandemDiabetes CEO, John Sheridan. https://childrenwithdiabetes.com/cwd-news/fda-approves-tandems-control-iq/ …pic.twitter.com/Ys17YHeiXd
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je Tweet
Today’s authorization by the U.S. Food and Drug Administration (
@US_FDA) of the Tandem Control-IQ algorithm for use as part of a hybrid closed-loop system is a win for the#T1D community! http://ow.ly/Tvzf50xzFH9 pic.twitter.com/QuXlVeZpiJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Tadej Battelino proslijedio/la je Tweet
Elections are over- the year is drawing to a close. Heads together with the dream team to plan the year ahead in
#T1D care ...and oh aren’t they ambitious indeed
Just like the days of @youngdiab#Trinity#gbdoc@drpratikc@WilmotEmma@drpratikcpic.twitter.com/8KHXUDBgR4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tadej Battelino proslijedio/la je Tweet
When you've been working hard &your
#TiR (time in range) percentage hs steadily increased since early November - and then BOOM, you find yourself smack dab in the middle of day 2 of craptastical numbers.#OhHeyDiabetes#doc#diabetes#dsma#shittygraph#YesIchangedOutMyPodHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Prof Ram Weis: we should be humble in our promises to people with
#diabetes about T1D prevention as we do not understand the disease

@ispad_org@jenious_ispad@Innodiagroup@UniPadovapic.twitter.com/pCicxejtKD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
